1,411 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
Will J&J (JNJ) Roll Out Pharma Q4 Earnings With a Beat? http://www.zacks.com/stock/news/722277/will-jj-jnj-roll-out-pharma-q4-earnings-with-a-beat?cid=CS-ZC-FT-analyst_blog|earnings_preview-722277 Jan 17, 2020 - J&J's (JNJ) cancer drugs are expected to have contributed significantly to fourth-quarter 2019 earnings. Generic/biosimilar headwinds are expected to have hurt Pharma unit's sales.
Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates http://www.zacks.com/stock/news/722255/pharma-stock-roundup-lly-dermira-buyout-offer-pipeline-regulatory-updates?cid=CS-ZC-FT-analyst_blog|stock_roundup-722255 Jan 17, 2020 - Lilly (LLY) offers to buy Dermira for $1.1 billion. AstraZeneca (AZN) and AbbVie (ABBV) provide pipeline updates.
Novartis Starts 2020 a Step Ahead of Other Big Pharmas with the Most Newly Approved Drugs https://www.fool.com/investing/2020/01/15/novartis-starts-2020-a-step-ahead-of-other-big-pha.aspx?source=iedfolrf0000001 Jan 15, 2020 - New treatments for breast cancer, multiple sclerosis, and others make the drugmaker's stock a more compelling buy in 2020.
AbbVie and Boehringer Ingelheim's Skyrizi Beat Novartis' Cosentyx in Plaque Psoriasis https://www.fool.com/investing/2020/01/14/abbvie-and-boehringer-ingelheims-skyrizi-beat-nova.aspx?source=iedfolrf0000001 Jan 14, 2020 - The results should help the upstart drug to compete with Cosentyx.
Novartis' Heart Drug Gets Accelerated Review in Britain for High-Risk Patients https://www.fool.com/investing/2020/01/13/novartis-heart-drug-gets-accelerated-review-in-bri.aspx?source=iedfolrf0000001 Jan 13, 2020 - Cholesterol-lowering inclisiran could be available in the country as early as 2021.
Alnylam Provides Preliminary Q4 Sales for Onpattro & Givlaari http://www.zacks.com/stock/news/715658/alnylam-provides-preliminary-q4-sales-for-onpattro-givlaari?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-715658 Jan 13, 2020 - Alnylam (ALNY) announces preliminary results for the fourth quarter and 2019 and provides other updates.
The Zacks Analyst Blog Highlights: Novartis, McDonald's, Bristol-Myers Squibb, CME and UBS http://www.zacks.com/stock/news/711468/the-zacks-analyst-blog-highlights-novartis-mcdonalds-bristol-myers-squibb-cme-and-ubs?cid=CS-ZC-FT-press_releases-711468 Jan 10, 2020 - The Zacks Analyst Blog Highlights: Novartis, McDonald's, Bristol-Myers Squibb, CME and UBS
Top Analyst Reports for Novartis, McDonald's & Bristol-Myers Squibb http://www.zacks.com/research-daily/709865/top-analyst-reports-for-novartis-mcdonalds-bristol-myers-squibb?cid=CS-ZC-FT-research_daily-709865 Jan 09, 2020 - Top Analyst Reports for Novartis, McDonald's & Bristol-Myers Squibb
NV Energy's planned largest U.S. solar farm posed for approval https://seekingalpha.com/news/3529198-nv-energys-planned-largest-u-s-solar-farm-posed-for-approval?utm_source=feed_news_all&utm_medium=referral Jan 02, 2020 - The Gemini Solar Project in Nevada, which is expected to be the largest solar PV project in the U.S., moves closer to government approval after the Bureau of Land Management released a favorable final
Are Investors Undervaluing Aegon NV (AEG) Right Now? http://www.zacks.com/stock/news/696275/are-investors-undervaluing-aegon-nv-aeg-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-696275 Dec 31, 2019 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Pages: 1234567...142

<Page 2>